Percutaneous Coronary Intervention and Triglyceride/Glucose Index: Points to Discuss
PDF

Letter to the Editor

Percutaneous Coronary Intervention and Triglyceride/Glucose Index: Points to Discuss

Bull Cardiovasc Acad 2025;3(1):60-61 DOI: 10.4274/kvbulten.galenos.2025.69875
, , , ,
PDF
Permissions

References

1

Öztürk E, Evrin T. Relation of the triglyceride/glucose index with the severity of the coronary artery disease in patients who underwent percutaneous coronary intervention. Bull Cardiovasc Acad. 2024;2(3):69-67.

2

Tang L, Xu X, Chen M, Li J, Pu X. Association of triglyceride-glucose index with severity of coronary artery disease among male patients. Sci Rep. 2024;14(1):20342.

3

Özmen M, Arikan E, Ozel F, Ardahanlı İ. Triglyceride-glucose index: Evaluation as a potential new risk marker for SYNTAX score in acute coronary syndrome. Int J Cardiovasc Sci. 2024;37:e20240096.

4

Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986-988.

5

Akbar MR, Pranata R, Wibowo A, Irvan, Sihite TA, Martha JW. The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(11):3024-3030.

6

Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.

7

Shaya GE, Leucker TM, Jones SR, Martin SS, Toth PP. Coronary heart disease risk: Low-density lipoprotein and beyond. Trends Cardiovasc Med. 2022;32(4):181-194.

8

Ardahanli I, Ozmen M. Letter by Isa Ardahanli regarding article, statins ticagrelor and rhabdomyolysis: A coincidence or a drug Interaction? J Lipid Atheroscler. 2025;14(1):128-129.